BioSig Technologies, Inc Stock News

BioSig Technologies Inc (NASDAQ:BSGM) announced that it has installed its PURE EP ECG signal processing platform system at New York-Presbyterian/Weill Cornell Medical Center in New York. Weill Cornell

The Company installs its novel medical technology platform for arrhythmia care in a leading Center of Excellence The Company installs its novel medical technology platform for arrhythmia care in a lea

According to a recently filed 8-k, BioSig Technologies, Inc. (NASDAQ: BSGM) received a new purchase order from the Mayo Foundation for medical education and research. The institution commenced the eva

BioSig Technologies Inc (NASDAQ: BSGM) has priced its previously announced underwritten public offering of 2.5 million shares at $4.00 per share, representing a discount of 8% from the last close pr

BioSig Technologies Inc (NASDAQ:BSGM) has announced the pricing of its underwritten public offering to raise about $10 million.  In a statement, the company said it could gain roughly an additional $

Westport, CT, July 02, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative biomedical sign

Westport, CT, July 01, 2021 (GLOBE NEWSWIRE) --   BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative biomedical s

According to recent reports, the global electroceuticals/bioelectric medicine market is currently worth $16.8 billion and is projected to reach $21.5 billion by 2026, at a compound annual growth rate

BioSig Technologies Inc (NASDAQ:BSGM) has announced that physicians have completed 1,000 patient cases with its technology across nine installation sites. The company's non-invasive computerized techn

The Company recently increased its procedural volume targets due to accelerated technology usage BioSig expands its commercial team to target technology adoption across three strategic regions

The Company recently increased its procedural volume targets due to accelerated technology usage BioSig expands its commercial team to target technology adoption across three strategic regions

Westport, CT, June 30, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative biomedical s

Abstracts are due to be presented by physician users and research investigators from two leading institutions Abstracts are due to be presented by physician users and research investigators from two l

BioSig Technologies Inc (NASDAQ:BSGM) has announced that it will present an exhibit at the Heart Rhythm 2021 convention, held July 28-31 at the Boston Convention and Exhibition Center. The company's e

Presentation on Tuesday, June 8, 2021, at 5 PM ET Presentation on Tuesday, June 8, 2021, at 5 PM ET